Home>Topics>>Takeaways From Teva's Analyst Day: 'Restoring Shareholder Value'

Takeaways From Teva's Analyst Day: 'Restoring Shareholder Value'

Israel Stocks News and Analysis from Seeking Alpha

Thu, 20 Dec 2012

By Logical Assessment : Thesis Following Teva Pharmaceutical's ( TEVA ) Analyst Day , investors were met with a disappointing sell off of roughly 10% within a week, in response to downgrades issued by Leerink Swann and RBC. Teva CEO Jeremy Levin's words appeared to indicate a shift in strategy, ...

Related Videos

  1. Prescribe to Pharma for Emerging-Markets Growth

    Thu, 12 Dec 2013

    Many developed-country health-care firms have deep roots in emerging markets and can be a good way to gain exposure, says Morningstar's Damien Conover.

  2. NOV Ready to Go Global

    Wed, 9 Jan 2013

    Morningstar CEO of the Year Pete Miller of National Oilwell Varco sees sustainable drilling prospects worldwide and expects the firm to use its expertise honed in the U.S. to take advantage of a global boom.

Content Partners